The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Nasretdinov A.F.

Republican Clinical Oncology Dispensary

Sultanbaev A.V.

Republican Clinical Oncology Dispensary

Menshikov K.V.

Republican Clinical Oncology Dispensary;
Bashkir State Medical University

Musin Sh.I.

Republican Clinical Oncology Dispensary

Sultanbaeva N.I.

Republican Clinical Oncology Dispensary

Izmailov A.A.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Health of Russia

New opportunities of drug therapy in patients with lung adenocarcinoma with ALK translocation

Authors:

Nasretdinov A.F., Sultanbaev A.V., Menshikov K.V., Musin Sh.I., Sultanbaeva N.I., Izmailov A.A.

More about the authors

Journal: P.A. Herzen Journal of Oncology. 2020;9(5): 48‑52

Views: 1774

Downloaded: 21


To cite this article:

Nasretdinov AF, Sultanbaev AV, Menshikov KV, Musin ShI, Sultanbaeva NI, Izmailov AA. New opportunities of drug therapy in patients with lung adenocarcinoma with ALK translocation. P.A. Herzen Journal of Oncology. 2020;9(5):48‑52. (In Russ.)
https://doi.org/10.17116/onkolog2020905148

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.